Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPROSTADIL vs BIMATOPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALPROSTADIL vs BIMATOPROST: Safety Overview

Metric ALPROSTADIL BIMATOPROST
Total FAERS Reports 2,800 14,752
Deaths Reported 60 74
Death Rate 2.1% 0.5%
Hospitalizations 210 245
Average Patient Age 62.5 yrs 62.3 yrs
% Female Patients 4.9% 77.6%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 12, 2019
Manufacturer ENDO USA, Inc. Gland Pharma Limited
Route INTRACAVERNOUS OPHTHALMIC
Marketing Status Prescription Discontinued